2023-07-06 08:32:06 ET
- Allarity Therapeutics ALLR -53% after pricing public offering to $11M
- ASLAN Pharmaceuticals Limited ( ASLN ) -33% to host webcast on July 6, 2023, to discuss phase 2b topline data from TREK-AD trial evaluating Eblasakimab in atopic dermatitis.
- VBI Vaccines ( VBIV ) -26% .
- Impel Pharmaceuticals ( IMPL ) -11% .
- Nocera ( NCRA ) -10% .
- Affirm Holdings ( AFRM ) -6% .
- Renalytix ( RNLX ) -6% .
- Freight Technologies ( FRGT ) -5% completes trucker tools integration , significantly expanding network scope.
- C4 Therapeutics ( CCCC ) -5% .
For further details see:
CCCC and AFRM among pre-market losers